Myth or Real? The Potential Serious Side Effects of
Ticagrelor

Wassam EL Din Hadad EL Shafey

Abstract

Myth or Real? The Potential Serious Side Effects of Ticagrelor

Ticagrelor, a novel direct, reversibly binding P2Y12 antagonist, has better pharmacodynamic effects and improves clinical outcomes compared with clopidogrel in the setting of ACS. However, ticagrelor-related dyspnea and bradyarrhythmias have been observed in the PLATO trial, here in my case I will present a case of ticagrelor side effects and how it may burden the course of hospital stay.

Author(s):

Wassam EL Din Hadad EL Shafey

Abstract | Full-Text | PDF

Share this